Centre Hospitalier Universite De Sherbrooke - Hôtel-Dieu Hospital /ID# 268900

Sherbrooke, Quebec J1G 2E8

0 studies enrolling now · 1 studies all time

What they study most

Fallopian Tube Cancer, High Grade Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer — Running, not enrolling